Department of Pathology & Laboratory Medicine, Division of Clinical Biochemistry, Saskatoon Health Region, Saskatoon, Saskatchewan, Canada
Dr. Andrew Lyon pursued biochemistry at Queen’s University in Kingston, Canada obtaining a BSc in 1983 and PhD in 1988. He trained as a clinical chemist at the University of Ottawa and in clinical toxicology at the University of Washington. He is a fellow of the Canadian Academy of Clinical Biochemistry a diplomat of the American Board of Clinical Chemistry.
Dr. Lyon has served many leadership roles with the Canadian Society of Clinical Chemists, in provincial societies, the board of Canadian Academy of Clinical Biochemistry and was the IFCC website editor 2009-2011. Dr. Lyon is currently the Division Head of Clinical Biochemistry in Saskatoon and a clinical Associate Professor of Pathology and Laboratory Medicine at the University of Saskatchewan. He has a variety of research interests including cardiac biomarkers, diabetes biomarkers, point-of-care testing and evaluation of the medical applications of cannabinoids.